BSE Award For “Best Return To Investors” at
5th Annual Pharmaceutical Leadership Awards 2012 Intensifies
Aanjaneya Lifecare, Divis Laboratories, TTK Healthcare,Ajanta Pharma
are in the race for the prestigious title as India votes to choose the company
who has maximized their Returns on Investments.
Mumbai, September 13,
2012: Pharrmaleaders, Asia’s biggest title in healthcare communications
is gearing up to choose the top Pharmaceutical & Biotech Companies for
their dramatic & significant accomplishments in their respective field at
the 5th Annual Pharmaceutical Leadership Awards 2012 in as many as
33 categories, the biggest & coveted title that India is anxiously looking
at is the Category that has made investors & stakeholder happy in the stock
market. Organized in association with BSE, Pharmexcil, IBEF & Ministry of
Industry & Commerce, Government of India, the coveted & prestigious title BSE Award for the Best Return to
Investors 2012 will be presented by Shri K. Shankaranarayan, His Excellency,
Governor of Maharashtra on Friday 21st September at Hotel Hilton
Mumbai International Airport amidst the presence of the veterans & who’s
who’s of the Asia’s top Healthcare Leaders, Pharma Academia, Ministers, Policy
Makers, Social Entrepreneurs & Medical Practioners. More than top 200
professionals of the Industry are expected to attend the much awaited
Leadership Event with the representation of Overseas Companies.
Speaking on the Award
Nomination, Kersi
Tavadia, CIO at Bombay Stock Exchange Limited said “Pharmaleaders has institutionalized Pharmaceutical
Leadership Awards since 1999 to honour & recognize the successful companies
& individuals who have made their mark & contributed vigorously to the
growth of Indian Economy & foreign exchange. Although there are many
successful Pharmaceutical Companies listed in BSE are doing well, however, the
attempt by the juries to nominate the mid-sized companies such as Aanjaneya Lifecare,
Divis Laboratories, TTK Healthcare,Ajanta Pharma are indeed judicious choices
as all four companies are doing exceedingly well in the Healthcare Index. The
Public, Investors & Companies who are choosing the Winner will truly be a
fitting recognition”. Satya Brahma, Chairman of the Juries &
Editor-In-Chief of Pharmaleaders said “ This category has attracted
tremendous attention in the stock market, Pharma Companies & in the general
public as corporate ethics, Corporate Sustainability Model are the norms of the
day & with so much of scrutiny by the regulators, BSE Award for the Best
Return to the Investors will be a tight contest”.
Kiran Kabtta Somvanshi
of ET said “ Of late there are many Midcaps in Healthcare
doing exceedingly well. Consider this, the stocks of most leading pharma
companies have hit a new high or a 52-week high since August. Stocks of
companies like Cipla, Sun Pharma, Lupin, Wockhardt, Strides Arcolabs, Divi's
Labs, Ipca Labs, Indoco Remedies Alembic Pharma and Shasun Pharma have hit a
new high on the bourses. Likewise, stocks of Ranbaxy Labs, Glenmark Pharma,
Dishman Pharma, Cadila Healthcare, Unichem Labs and Venus Remedies have hit a
52-week high. With macro economic conditions being difficult and most sectors
not doing well, the market is chasing all growth-oriented companies in the
defensive sectors of FMCG and now Pharma stocks, defensive sector, valuations,
FMCGarma.Given the limited opportunity in the market, the Street has now turned
to pharma stocks to capture growth and value. Most pharma companies with decent
growth performance has witnessed a rally in its stock. 32% of the total 148
listed pharma stocks have flared up to new or 52-week highs in the last one
month.The Indian pharma market is growing at 16-18%. Most Indian companies earn
substantial revenues from outside by selling low-cost generic drugs in
regulated markets. The industry is growing at an average rate of 20-22%. Many
Indian companies like Sun Pharma, Dr Reddy's Labs and Glenmark are among the fastest
growing generic companies in the world. With the market now chasing the drug
company stocks, the valuations of these companies is likely to become
expensive. The ET Pharma Index is trading at a price to earnings multiple of 33
very close to the 34.6 P/E of ET FMCG Index.
Dr Kannan Vishwanath led Aanjaneya Lifecare
which specializes in niche segments has a strong presence in API and
formulation business and has bulk drug manufacturing facility at Mahad and a
finished dosage forms unit near Pune. It is one of the largest contract
manufacturers of codeine-based cough syrups in India and exclusively makes
Codorex brand of Zydus Cadilla and Codilite tablets among others. It recently
raised around Rs 117 crore through an initial public offering (IPO). It acquired
recentlyApex Drugs and Intermediates (ADI), a Hyderabad-based integrated active
pharmaceutical ingredient (API) and intermediate company, for Rs.250 crore,
including debt of Rs.185 crore and equity dilution of Rs.65 crore.
Divi’s Laboratories has earned a consolidated total
income of Rs.722 crores for the 4th Quarter of the year 2011-12 as against a
total income of Rs.480 crores during the corresponding quarter last year,
reflecting a growth of 50%. Established in the year 1990, with Research &
Development as its prime fundamental, Divis
Laboratories focussed on developing new processes for the production of
Active Pharma Ingredients (APIs) & Intermediates. The company in a matter
of short time expanded its breadth of operations to provide complete turnkey
solutions to the domestic Indian pharmaceutical industry.
Purushottam B. Agrawal Led Ajanta Pharma
is a specialty pharmaceutical company engaged in the development, manufacture
and commercialization of pharmaceutical products. We employ over 3,500 people
worldwide and our products are sold in over 30 countries. Ajanta operates with
5 state-of-the art manufacturing facilities that produce high quality
pharmaceutical products. We focus on commercializing unique generic products
and pioneering synergistic combination products in the therapeutic areas of
anti- malarial, cardiology, dermatology, gastroenterology, musculoskeletal,
ophthalmology and respiratory is also doing quite well.
Chennai based TTK Healthcare manufactures
calcium supplements, haematinics, cervical dilators, thrombolytic agents,
rejuvenators, multimineral supplements, liver correctives and pain management
products.Besides being the first Pharmaceutical Company in India to be awarded
the ISO certification by BIS, TTK Healthcare was also the first to launch
technology-driven life-saving products like Urokinase and Dopamine. The Company
has also developed medicines like Lactare based on Ayurveda - the ancient
traditional system of medicine.
About 5th Annual
Pharmaceutical Leadership Awards 2012.
Pharmaceutical
Business Leadership Award Nominations 2012 has been carefully selected in 33
categories with several new entrants making it to the top category & big
league as a result of their rising market presence. While the traditional Award
Nominations have remained, some more categories have been created by the juries
to give justice to the young companies & Leaders, further a great emphasis
has been given to some of the unsung heroes & their innovative growth
Stories. Pharmaleaders has taken every possible steps to keep the award
nominations credible & newsworthy. While more than 500 top houses have been
honored with their names featuring in Annual Reports & international
platforms, Pharmaceutical Leadership Business Leadership Awards are widely
perceived to be most credible & independent & free from political
interference. The three tier judging mechanism allows each nominee to undergo a
public scrutiny first by the SMS, Email & than the eminent Juries will
decide the fate of achievers tonight. In a significant development,
Pharmaleaders has introduced a unique mechanism of creating mote than 5 Lakh
sample size consisting of Companies, Pharmacy Education, Trade, Investors &
Doctors.
Originally
launched in 1999 as the Pharma Business & Technology Excellence Awards, The
Excellence Awards were first produced for the first time in India by the PHARMA
BUSINESS & TECHNOLOGY MAGAZINE as a means of honoring innovation in
pharmaceutical marketing, corporate governance, Research and development &
Lifetime Achievements category. Pharma Excellence Awards were produced by
PHARMA BUSINESS & TECHNOLOGY MAGAZINE Awards in India and expanded to
recognize global corporate citizenship and individual achievements. Over the
last one decade, Pharmaceutical business leadership awards 2012 has been
re-evaluated and recast to focus more on business-scientific accomplishments in
the biotech industry with a significant thrust in academic pharmaceutical
research. The set of awards have been presented since last one decade at a
sold-out gala to over 500 industry executives and leading academic scientists
from around the world. Each Award or Nomination are being screened by the Board
Members of Pharma Leaders Group consisting of 12 Member Team & than further
approved by Network 7 Media Group Editorial Members from Pharmanewsprwire,
Indian Affairs Juries consisting of eminent members of the Healthcare
Community. After through screening, the names of four Nominees emerge out &
are thrown out to public by E-mail Voting, Than SMS Voting followed by the
final verdict of the Jury Members. The Awards demonstrate how companies can,
through their core business activities, help achieve excellence in innovations.
The 2012 Award Nominations has been given explicitly to companies delivering
inclusive business models which are sustainable, commercially-viable business
initiatives that expand access for low-income people to goods and services, or
improve their livelihoods by engagement in value chains as direct employees,
suppliers or distributors, while also generating sales and profit growth. By
bringing together examples of innovative, effective business practices, 5th
Annual Pharmaceutical Leadership Awards will also provide leading businesses
and entrepreneurs with a valuable platform for networking and sharing
experiences, and promote best practices. This will encourage other businesses
and governments to replicate and scale initiatives. In 2011, the Awards
received an unprecedented 172 nominations, representing a variety of business
and commercial endeavors undertaken by business associations, non-governmental
organizations and individual companies from more than 9 countries with a sample
size of 5 Lakh 56 thousand & 674 voters spread across 21 states & 4 industry verticals via online,
sms & physical interviews . “Past Award winners have shown how companies
can help boost sustainable growth and development & they can be a tremendous
source of innovative and sustainable solutions, which help transform people’s
lives for the better." These Awards will highlight the critical role of
the private sector in stimulating sustainable economic growth and development.
A detailed Analysis of career graph/History or notable achievement is looked at
to get the final four names. Such as
• Financial management,
• Decision making roles and business
impact. •Business ethics.
• Managing rapid growth.
• Innovation.
• Adapting to change.
• Strategic partnerships.
• Leadership roles.
• Marketing strategies.
• Corporate philanthropy to society.
The
Award for the Best Return to Investors will be presented once the results for
the Nomination process will end & the final vote count on 21st
September . The Winner will be presented an Award Trophy & a certificate of
Excellence.
No comments:
Post a Comment